|
1
|
Tsunoda AT, Marnitz S, Soares Nunes J,
Mattos de Cunha Andrade CE, Scapulatempo Neto C, Blohmer JU,
Herrmann J, Kerr LM, Martus P, Schneider A, et al: Incidence of
histologically proven pelvic and Para-aortic lymph node metastases
and rate of upstaging in patients with locally advanced cervical
cancer: Results of a prospective randomized trial. Oncology.
92:213–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Azevedo C, Thuler LCS, de Mello MJG, de
Oliveira Lima JT, da Fonte ALF, Fontão DFS, Carneiro VCG, Chang TMC
and Ferreira CG: Phase II trial of neoadjuvant chemotherapy
followed by chemoradiation in locally advanced cervical cancer.
Gynecol Oncol. 146:560–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matijevic M, Hedley ML, Urban RG, Chicz
RM, Lajoie C and Luby TM: Immunization with a poly (lactide
co-glycolide) encapsulated plasmid DNA expressing antigenic regions
of HPV 16 and 18 results in an increase in the precursor frequency
of T cells that respond to epitopes from HPV 16, 18, 6 and 11. Cell
Immunol. 270:62–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Varghese VK, Shukla V, Kabekkodu SP,
Pandey D and Satyamoorthy K: DNA methylation regulated microRNAs in
human cervical cancer. Mol Carcinog. 57:370–382. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shishodia G, Verma G, Das BC and Bharti
AC: miRNA as viral transcription tuners in HPV-mediated cervical
carcinogenesis. Front Biosci. 10:21–47. 2018. View Article : Google Scholar
|
|
6
|
Liang C, Ding J, Yang Y, Deng L and Li X:
MicroRNA-433 inhibits cervical cancer progression by directly
targeting metadherin to regulate the AKT and β-catenin signalling
pathways. Oncol Rep. 38:3639–3649. 2017.PubMed/NCBI
|
|
7
|
Hou F, Li Z, Ma D, Zhang W, Zhang Y, Zhang
T, Kong B and Cui B: Distribution of Th17 cells and
Foxp3-expressing T cells in tumor-infiltrating lymphocytes in
patients with uterine cervical cancer. Clin Chim Acta.
413:1848–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Q, Lou XM and He Y: Preferential
recruitment of Th17 cells to cervical cancer via CCR6-CCL20
pathway. PLoS One. 10:e01208552015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang W, Tian X, Mumtahana F, Jiao J,
Zhang T, Croce KD, Ma D, Kong B and Cui B: The existence of Th22,
pure Th17 and Th1 cells in CIN and cervical cancer along with their
frequency variation in different stages of cervical cancer. BMC
Cancer. 15:7172015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wakatsuki M, Kato S, Ohno T, Karasawa K,
Kiyohara H, Tamaki T, Ando K, Tsujii H, Nakano T, Kamada T, et al:
Clinical outcomes of carbon ion radiotherapy for locally advanced
adenocarcinoma of the uterine cervix in phase 1/2 clinical trial
(protocol 9704). Cancer. 120:1663–1669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sewali B, Okuyemi KS, Askhir A, Belinson
J, Vogel RI, Joseph A and Ghebre RG: Cervical cancer screening with
clinic-based Pap test versus home HPV test among Somali immigrant
women in Minnesota: A pilot randomized controlled trial. Cancer
Med. 4:620–631. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He X, Zheng Y, Liu S, Shi S, Liu Y, He Y,
Zhang C and Zhou X: MiR-146a protects small intestine against
ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-kappaB
pathway. J Cell Physiol. 233:2476–2488. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tristão FS, Rocha FA, Carlos D,
Ketelut-Carneiro N, Souza COS, Milanezi CM and Silva JS:
Th17-inducing cytokines IL-6 and IL-23 are crucial for granuloma
formation during experimental paracoccidioidomycosis. Front
Immunol. 8:9492017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Wang X, Choi IY, Wang YC, Liu S,
Pham AT, Moon H, Smith DJ, Rao DS, Boldin MP, et al: miR-146a
modulates autoreactive Th17 cell differentiation and regulates
organ-specific autoimmunity. J Clin Invest. 127:3702–3716. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yoon JH, Sudo K, Kuroda M, Kato M, Lee IK,
Han JS, Nakae S, Imamura T, Kim J, Ju JH, et al: Phosphorylation
status determines the opposing functions of Smad2/Smad3 as STAT3
cofactors in TH17 differentiation. Nat Commun.
6:76002015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SY, Lee SH, Yang EJ, Kim JK, Kim EK,
Jung K, Jung H, Lee K, Lee HH, Lee BI, et al: Coenzyme Q10 inhibits
Th17 and STAT3 signaling pathways to ameliorate colitis in mice. J
Med Food. 20:821–829. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SH, Park JS, Byun JK, Jhun J, Jung K,
Seo HB, Moon YM, Kim HY, Park SH and Cho ML: Corrigendum: PTEN
ameliorates autoimmune arthritis through down-regulating STAT3
activation with reciprocal balance of Th17 and Tregs. Sci Rep.
7:422672017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Betts BC, Sagatys EM, Veerapathran A,
Lloyd MC, Beato F, Lawrence HR, Yue B, Kim J, Sebti SM, Anasetti C,
et al: CD4+ T cell STAT3 phosphorylation precedes acute
GVHD, and subsequent Th17 tissue invasion correlates with GVHD
severity and therapeutic response. J Leukoc Biol. 97:807–819. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou T, Lin H, Cheng Z, Ji C, Zhang C and
Tian J: Mechanism of microRNA-146a-mediated IL-6/STAT3 signaling in
lumbar intervertebral disc degeneration. Exp Ther Med.
14:1131–1135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu N, Xu M, Mizoguchi I, Furusawa J,
Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y and Yoshimoto
T: Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22,
and IL-23, in inflammatory diseases. Clin Dev Immunol.
2013:9685492013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Xu K, Wu J, Luo C, Li Y, Wu X, Gao
H, Feng G and Yuan BZ: The changes of Th17 cells and the related
cytokines in the progression of human colorectal cancers. BMC
Cancer. 12:4182012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan CK, Andraski AB, Spolski R, Li P,
Kazemian M, Oh J, Samsel L, Swanson PA II, McGavern DB, Sampaio EP,
et al: Opposing roles of STAT1 and STAT3 in IL-21 function in
CD4+ T cells. Proc Natl Acad Sci USA. 112:9394–9399.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Halwani R, Sultana A, Vazquez-Tello A,
Jamhawi A, Al-Masri AA and Al-Muhsen S: Th-17 regulatory cytokines
IL-21, IL-23, and IL-6 enhance neutrophil production of IL-17
cytokines during asthma. J Asthma. 54:893–904. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye EA and Steinle JJ: miR-146a suppresses
STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in
primary human retinal microvascular endothelial cells in high
glucose conditions. Vision Res. 139:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
